TI
DYN icon

Trexquant Investment’s Dyne Therapeutics DYN Stock Holding History

Trexquant Investment’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,641
Closed -$501K – 1970
2026
Q1 		$501K Sell
27,641
-73,004
-73% -$1.26M ﹤0.01% 1468
2025
Q4 		$1.97M Sell
100,645
-244,817
-71% -$4.64M 0.02% 997
2025
Q3 		$4.37M Sell
345,462
-16,848
-5% -$192K 0.05% 601
2025
Q2 		$3.45M Buy
362,310
+27,867
+8% +$307K 0.04% 676
2025
Q1 		$3.5M Buy
334,443
+209,065
+167% +$2.99M 0.04% 653
2024
Q4 		$2.95M Buy
125,378
+61,288
+96% +$1.81M 0.03% 714
2024
Q3 		$2.3M Sell
64,090
-17,872
-22% -$711K 0.03% 759
2024
Q2 		$2.89M Buy
81,962
+42,983
+110% +$1.25M 0.04% 595
2024
Q1 		$1.11M Buy
38,979
+16,157
+71% +$365K 0.02% 881
2023
Q4 		$304K Buy
+22,822
New +$223K 0.01% 1246
2023
Q3 		– Sell
-27,380
Closed -$308K – 1544
2023
Q2 		$308K Sell
27,380
-15,089
-36% -$178K 0.01% 1187
2023
Q1 		$489K Buy
42,469
+14,378
+51% +$187K 0.01% 1009
2022
Q4 		$326K Sell
28,091
-8,476
-23% -$98.1K 0.01% 1073
2022
Q3 		$464K Buy
+36,567
New +$419K 0.02% 843
2022
Q1 		– Sell
-20,232
Closed -$241K – 1441
2021
Q4 		$241K Sell
20,232
-7,622
-27% -$107K 0.01% 1039
2021
Q3 		$452K Buy
+27,854
New +$494K 0.04% 577

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Trexquant Investment's DYN Position: Q2 2026 in Review

Trexquant Investment sold out of Dyne Therapeutics (DYN) in Q2 2026, closing a stake of 27,641 shares — an estimated $501K sold.

Trexquant Investment first reported a position in DYN in Q3 2021 and held it in 16 quarters. The position peaked at $4.37M in Q3 2025. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Trexquant Investment reported no remaining Dyne Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 27,641 Dyne Therapeutics shares in Q2 2026, an estimated $501K.
  • Trexquant Investment first reported a position in Dyne Therapeutics in Q3 2021 and held it in 16 quarters.
  • Trexquant Investment's Dyne Therapeutics position peaked at $4.37M in Q3 2025.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.